Effect of Saccharomyces Boulardii on Indirect Hyperbilirubinemia and Phototherapy Duration in Very Low Birth Weight Infants
NCT ID: NCT01411761
Last Updated: 2011-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
80 participants
INTERVENTIONAL
2011-05-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Synbiotics on Morbidity and Mortality in Preterm Infants
NCT01807858
Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia
NCT03266913
Effect of Early Limited Formula on Total Serum Bilirubin Among Newborns With Hyperbilirubinemia
NCT01330667
Effectiveness of Phototherapy With and Without Probiotics
NCT06173856
Effects of Lactobacillus Reuteri in Premature Infants
NCT01181791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Saccharomyces boulardii
study group
Reflor
5 million unit/day, first 15 day of life
placebo
serum physiologic
serum physiologic
1 cc added to one feeding in a day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reflor
5 million unit/day, first 15 day of life
serum physiologic
1 cc added to one feeding in a day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Day
15 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zekai Tahir Burak Women's Health Research and Education Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zekai Tahir Burak Maternity and Teaching Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gamze Demirel, MD
Role: PRINCIPAL_INVESTIGATOR
Zekai Tahir Burak Women's Health Research and Education Hospital
Ugur Dilmen, Prof
Role: STUDY_DIRECTOR
Zekai Tahir Burak Maternit Teaching Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Omer Erdeve, Assoc Prof
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
demirel9800
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.